The world of pharma regulations is constantly evolving, presenting new challenges and opportunities. In this ever-changing environment, continuous learning is key. Therefore, Express Pharma is launching “Regulatory Watch” a series of Master Classes led by experts and thought leaders to empower you with the knowledge and insights needed to navigate the ever-changing regulatory landscape successfully.
The second Master Class in this series is by Mr Masihuddin Jaigirdar on Product & Process related regulatory issues in the submitted ANDAs.
It will be divided into three sessions:
The first session highlighted the Critical Areas to be Focused on for Quality Submissions.
The second session covered Drug Product & Manufacturing and this video, the third session, will focus on Common Deficiencies during Scale-up.